Citizens reiterates Prime Medicine stock rating on gene therapy focus

Citizens reiterates Prime Medicine stock rating on gene therapy focus

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.